Back to search

National and Kapodistrian University of Athens

Μελέτη της έκφρασης του παράγοντα COX - 2 σε ασθενείς που αντιμετωπίσθηκαν με μετεγχειρητική χημειοθεραπεία paclitaxel / carboplatin για διηθητικό καρκίνο ουροδόχου κύστεως: συσχέτιση με απόπτωση, κυτταρικό πολλαπλασιασμό, αγγειογένεση και προγνωστική σημασία

Abstract

dc:description

Urothelial cancer is a common malignancy. The treatment of choice for muscle- invasive urothelial cancer is radical cystectomy and the prognosis is related to the pathological stage of the disease. Systemic neoadjuvant and adjuvant chemotherapy has been used in order to improve prognosis. Biological factors may be adoperated to define groups of patients with different prognosis that may benefit from different therapeutic approaches. Cycloxygenase-2 (COX-2) is an isoenzyme implicated in the production of prostaglandins and related to apoptosis, cellular proliferation and angiogenesis. Prognostic significance of COX-2 was studied in patients with muscle- invasive urothelial cancer and high risk for relapse (pT3a, pT3b or pT4a or lymph node metastases, but not distal metastases), that had undergone surgery followed by adjuvant chemotherapy with paclitaxel/ carboplatin. The methods used were immunohistochemistry and reverse transcription- polymerase chain reaction (RT-PCR). Immunohistochemical expression of COX-2 in 59 patients, of p53 in 52 patients, of ki-67 in 57 patients and of microvessel density (MVD) in 50 patients were studied. On the other hand, COX-2 RNA and VEGF RNA were studied in 43 patients. Correlations with age, sex, pathological T stage, tumor location, lymph node metastases and vascular invasion, as well as overall survival and disease free survival were done. Immunohistochemical expression of COX-2 was positive in 64% of the patients, but no correlation was found with overall survival and disease free survival. Expression of COX-2 RNA was found positive only in 20,9% of the the patients and, in this case also, there was no correlation with overall survival and disease free survival. Interestingly, VEGF RNA expression was observed almost exclusively in those patients that were immunohistochemically positive for COX-2. As far as microvessel density was concerned, levels of MVD ?47 were associated with longer disease free survival that was statistically significant. These results could be attributed to the small number of patients that were included in the analysis, as well as to the difficulties encountered in extracting RNA from the material used for the study. Of all the factors studied, microvessel density (MVD) could serve as a useful indicator of relapse in patients with muscle- invasive urothelial cancer treated with adjuvant chemotherapy.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kyriakou, Fani
  • Κυριάκου, Φανή

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24361

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kyriakou, Fani; Κυριάκου, Φανή. Μελέτη της έκφρασης του παράγοντα COX - 2 σε ασθενείς που αντιμετωπίσθηκαν με μετεγχειρητική χημειοθεραπεία paclitaxel / carboplatin για διηθητικό καρκίνο ουροδόχου κύστεως: συσχέτιση με απόπτωση, κυτταρικό πολλαπλασιασμό, αγγειογένεση και προγνωστική σημασία. National and Kapodistrian University of Athens, 2010. http://hdl.handle.net/10442/hedi/24361